EcoBlu Products Inc. (OTC: ECOB) has signed an exclusive licensing
agreement with fire protection supplier Megola

Check it Out    http://www.sddt.com/news/article.cfm?SourceCode=20091119czb

An Eco-Friendly WORLD is a DREAM of all and ECO Blu Products ECOB is
one such stepping stone towards it.  www.EcoBluProducts.com

ECOB  Products; a fully integrated chemical coating plant located in
Southern California and Northeast Texas, poised to impact housing
industry on many levels.

ECOB aims at preventing rot, mildew, fungus, termite infestation,
along with effective fire retardant. Coated wood lasts Lifelong;
increases sustainability of forests.

Estimated Market demand for treated lumber is $11 Billion by 2010.
Demand for lumber and engineering wood products is expected to be $18
Billion.

The management team made up to Founder Steve Conboy and EVP Mark
Vuzzo, having more than 30 years of experience each; and the Advisory
team consisting of Ken McClelland- president of McClelland
Organization. The ECoBlu seems to be in have a great leaders.

ECO Blu is superbly positioned to take advantage in this rapidly
increasing eco friendly and Green market.
ECOB  have an estimated growth of about $6 billion within 3 years.
This would represent a gain of over 200% from current level.

The wood chemical market enjoyed $2 Billion in revenues in 2007, ones
the global financial market recovers the revenues are expected to
exceed the numbers.

Partnership with Lowe’s had enabled EcoBlu to implement new strategies
and boost contractor sales.

EcoBlu have established Nationwide Sales and Marketing of coatings
chemistry in South America, Caribbean, Africa and Asia.

A Three year plan of ECOB calls for direct selling of chemicals
coatings to mills, EWP manufacturers and independent coaters in the US
and elsewhere, than just selling to retailers and other small
builders.

Check out Complete Presentation only at www.stockexploder.com

 Please do your own due diligence on ECOB

SINOBIOPHRMA INC "soared" 93% with two trading Days after my alert !
Congratulations!!!

Today SINOBIOPHRMA INC traded as high of  0.39 on over 5,000,000
shares traded

I gave this to you at 0.20 for Monday's trade....

Ok, so what’s next you ask? I have something even bigger...

Why it's in your best interest to buy  and Full Presentation on Entest
BioMedical Inc

Bio-tech companies are a great investment right now, according to many
financial experts. Support from the Obama administration will ensure
this trend continues.

Between the current administration rallying behind Bio-tech and
Stimulus plan. This is a great combo to ensure if you pick the right
Bio-tech stock you can make massive gains quickly.

"WALL STREET IS ALWAYS LOOKING” For the Next Big Thing.......

Whether it's a cure for cancer or a fountain of youth , the script
can be all-too-familiar Financially, 2009 has been a hard year.

Almost every industry sector has suffered....

But financial experts wouldn't be experts if they couldn't find a
sector that will do better than the others, and that will offer
substantial returns

to investors.

Biotech is what they recommend

Forbes interviewed two top-notch analysts in this area, Eric Schmidt
and Ross Muken. They both agree that there is money to be made by
investing in biotech.

Bottom line is this... You have a choice,

You can take action and buy Entest BioMedical Inc now!
or wait to buy it at potentially $3.50 per share

This is set to soar!!

Exploder

SNBP is our New Pick www.sinobiopharma.com

SINO BIOPHARMA SNBP a Fully integrated specality biopharmaceutical
company with 30,000 sq.meter Certified Production Facilities in China.

Estimated Chinese Health Care Market Demand of $600 Billion by 2015.We
all are aware China’s Current population is 1.4 Billion.

SNBP traded as high as $2.0 in the PAST, we can shoot for a gain of
8400%

Leadership of CEO Dr. Lequn Lee Huang a former manager of the Bayer
Co., one of the world's largest pharmaceutical companies and CFO Mr.
Dong Ying formerly of JP Morgan Chase.

SNBP Anesthetics Projected sale of 1.5 million units and 500,000
tablets for cardiovascular diseases in 2009.

Key Drives:
Outstanding financial results; more than 2000% growth in 3 years.
4 key marketed products; multiple products in pipeline.
R&D Partnership with Cornell University and 3 Top Universities in
China.
Established Nation wide Sales and Marketing Network in China.
Aging Population & Increasing Life Style diseases.
Improving Health Insurance Programs and Coverage.

PLAN FOR FUTURE: Sinobiopharma has a clearly defined strategy to drive
short, middle and long term growth.  All drug development will
leverage the Company's patented technology for fast, low-cost drug
synthesis and new technology for formulation.

Check out Complete Presentation only at www.stockexploder.com
Please do your own due diligence on SNBP
All The Best

Exploder

www.stockexploder.com
 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html

On Oct 23, 8:48 am, jbug <jbugsto...@gmail.com> wrote:

Thank you very much for that last dip in price.  I'm averaged down and
all in at $10.21.  I probably should have waited a little longer but
according to my research and calculations,  this may very well be the
lowest that we will ever see this stock price.  Take a look at the ytd
chart or even the thirty day chart.  From my experience, this is going
to be one of those "exceptional" deals.  Good luck to all,  see you
next wed. / thur.